VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial
MedTech & Diagnostics

Pediatrix Medical Group Executive Compensation (FY25)

MD · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Mark Ordan
Latest say-on-pay support
=
May 7, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
See every company’s exec pay — free for 3 days, no cardSee the plan and pricing
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on Pediatrix Medical Group

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
15 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Pediatrix Medical Group brief$500Get the executive brief
Velarion Intel, one year, every company
289 figures on this page: 276 cited to the filing that reported them, 13 calculated from figures it prints. See the citations

More on Pediatrix Medical Group

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: James Swift → Mark Ordan

Frequently asked questions

Answers drawn from the data on this page.
Who is Pediatrix Medical Group's chief executive and what were they paid?
Mark Ordan was paid $14,140,217 in total compensation as Chief Executive Officer for fiscal 2025.
What was Pediatrix Medical Group's say-on-pay result?
The say-on-pay proposal drew 97.3% support at the meeting held May 7, 2026 for fiscal 2025.
Which companies are in Pediatrix Medical Group's peer group?
The disclosed peer group names Acadia Healthcare Company, Inc., Addus HomeCare Corporation, Amedisys, Inc., Aveanna Healthcare Holdings Inc. and Brookdale Senior Living, Inc., among others.
What is Pediatrix Medical Group's chief executive pay ratio?
The company reported a chief executive pay ratio of 91:1 for fiscal 2025, against median employee compensation of $155,070.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
C. Marc Richards
Former Executive Vice President, Chief Financial Officer
◇—◇———◇◇
James Swift
Former Chief Executive Officer
◇—◇—◇—◇◇
Mary Ann Moore
Executive Vice President, General Counsel, Chief Administrative Officer and Secretary
◇—◇—◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
James Swift
Former Chief Executive Officer
◇◇◇—◇—◇◇
Curtis Pickert
Former Executive Vice President, Chief Physician Executive
◇◇◇—◇—◇◇
Mary Ann Moore
Executive Vice President, General Counsel, Chief Administrative Officer and Secretary
◇◇◇—◇—◇◇
C. Marc Richards
Former Executive Vice President, Chief Financial Officer
◇◇◇—◇—◇◇
Lee Wood
Former Executive Vice President, National and Market Operations
◇◇◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
James Swift
Former Chief Executive Officer
◇—◇—◇—◇◇
C. Marc Richards
Former Executive Vice President, Chief Financial Officer
Departed during or after this year
◇—◇—◇—◇◇
Mary Ann Moore
Executive Vice President, General Counsel, Chief Administrative Officer and Secretary
◇—◇—◇—◇◇
Curtis Pickert
Former Executive Vice President, Chief Physician Executive
Departed during or after this year
◇—◇—◇—◇◇
Lee Wood
Former Executive Vice President, National and Market Operations
Departed during or after this year
◇—◇—◇—◇◇
Kasandra Rossi
Executive Vice President, Chief Financial Officer & Treasurer
◇—◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Mark Ordan
Chief Executive Officer
◇◇◇—◇—◇◇
Don Neeb
Executive Vice President, Chief Investment & Strategy Officer
◇◇◇—◇—◇◇
Mary Ann Moore
Executive Vice President, General Counsel, Chief Administrative Officer and Secretary
◇—◇—◇—◇◇
James Swift
Former Chief Executive Officer
Departed during or after this year
◇—◇—◇—◇◇
Kasandra Rossi
Executive Vice President, Chief Financial Officer and Treasurer
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Don Gregory NeebPSU◇◇◇—◇—◇
Don Gregory NeebRSU◇——◇——◇
Don Gregory NeebPSU◇◇◇—◇—◇
James D. SwiftPSU◇◇◇—◇—◇
James D. SwiftPSU◇◇◇—◇—◇
Kasandra H. RossiPSU◇◇◇—◇—◇
Kasandra H. RossiRSU◇——◇——◇
Kasandra H. RossiPSU◇◇◇—◇—◇
Mark S. OrdanPSU◇◇◇—◇—◇
Mark S. OrdanRSU◇——◇——◇
Mark S. OrdanPSU◇◇◇—◇—◇
Mary Ann E. MoorePSU◇◇◇—◇—◇
Mary Ann E. MoorePSU◇◇◇—◇—◇
Mary Ann E. MooreRSU◇——◇——◇
Mary Ann E. MoorePSU◇◇◇—◇—◇
Fiscal 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Mary Ann MooreRSU◇=——
Kasandra RossiRSU◇=——
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
Mary Ann E. MooreRSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
James SwiftPSU◇◇——
PSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Mark Ordan
Chief Executive Officer · Employment agreement · dated January 12, 2025
Severance multiple◇
Change-in-control multiple◇
Equity acceleration on change in control◇
Excise tax treatment◇
Non-compete period◇
Non-solicit period◇
Clawback◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Guy P. Sansone
Lead independent director
◇◇————◇
Thomas A. McEachin
◇◇————◇
Shirley A. Weis
◇◇————◇
Michael A. Rucker
◇◇————◇
Laura A. Linynsky
◇◇————◇
John M. Starcher Jr
◇◇————◇
Sylvia J. Young
◇◇————◇
Kurt D. Newman, M.D
◇◇————◇
Mark S. Ordan
Board chair
◇—————◇
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Lead independent director premium◇
Audit committee chair◇
Compensation committee chair◇
Nominating and governance chair◇
Equity is delivered as restricted stock units.
Stock ownership guideline: The chart below shows the multiple of base salary ownership requirements and actual ownership levels as of December 31, 2018: Dr. Medel 6x base salary; Mr. Calabro 4x base salary...

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Acadia Healthcare Company, Inc. HR
  • Addus HomeCare Corporation ADUS
  • Amedisys, Inc. AMED
  • Aveanna Healthcare Holdings Inc. AVAH
  • Brookdale Senior Living, Inc. BKD
  • Chemed Corporation CHE
  • Cross Country Healthcare, Inc. CCRN
  • Healthcare Services Group, Inc. HCSG
  • ModivCare Inc. MODV
  • National HealthCare Corporation NHC
  • Premier, Inc. PFC
  • RadNet, Inc. RDNT
  • Surgery Partners, Inc. SGRY
  • The Ensign Group, Inc. ENSG

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 7, 2026=◇◇◇
2024May 8, 2025=◇◇◇
2023May 9, 2024=◇◇◇
2022May 11, 2023=◇◇◇
2021May 12, 2022=◇◇◇
2020May 12, 2021=◇◇◇
2019September 9, 2020=◇◇◇
2018May 16, 2019=◇◇◇
2017May 16, 2018=◇◇◇
2016May 11, 2017=◇◇◇
2015May 12, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- James Swift (Former Chief Executive Officer), FY2025 total compensation $2,775,881 (base salary $54,167) [exec_comp, SEC accession 0001193125-26-127299, filed 2026-03-27]

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Tell me when Pediatrix Medical Group files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Pediatrix Medical Group disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Pediatrix Medical Group sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Pediatrix Medical Group's disclosed peer group is defensible, who names Pediatrix Medical Group back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
289 figures on this page: 276 cited to the filing that reported them, 13 calculated from figures it prints.
276 cited to the filing
13 calculated from the filing

Documents cited

  1. 0001193125-26-212117
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001193125-26-127299
    CEO Pay Ratio · Director Compensation · Grants of Plan-Based Awards in 2025 · Outstanding Equity Awards at 2025 Fiscal Year-End · and 1 more section
  3. 0000950170-25-067076
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0000950170-25-046327
    Summary Compensation Table
  5. 0000950170-25-023730
    EX-10.19
  6. 0000950170-24-057093
  7. 0001193125-24-079571
    Summary Compensation Table
  8. 0000950170-23-021326
  9. 0000950170-22-010201
  10. 0001193125-21-161991
  11. 0001193125-20-245502
  12. 0001193125-19-150702
    Item 5.07 Submission of Matters to a Vote of Security Holders
  13. 0001193125-18-166664
    Item 5.07 Submission of Matters to a Vote of Security Holders
  14. 0001193125-17-168626
    Item 5.07 Submission of Matters to a Vote of Security Holders
  15. 0001193125-16-590452
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Pediatrix Medical Group executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/MD (accessed 2026).
Short form: data: Velarion

The paid brief for Pediatrix Medical Group

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
15 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Pediatrix Medical Group and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

MedTech & Diagnostics rankings

Peers Pediatrix Medical Group discloses

The companies named in MD's own disclosed peer group.

Terms on this page

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}